User Image Cart Icon 0 Search Image

EF24 (Tumeric Root)

  1. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
  2. Abstract P4-16-02: EF24 targets radiation-induced NFkB-dependent stemness in triple negative breast cancer cells
  3. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy
  4. Analysis of the EF24-modulated signaling pathways for the development of novel cancer combination therapies
  5. Antibacterial activity of synthetic curcumin derivatives: 3, 5-bis (benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF 2 …
  6. Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
  7. Anticancer mechanism and application of curcumin analog EF24
  8. Anti-HIF Activity of curcumin and analog EF24.
  9. Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells
  10. Bioactivities of EF24, a novel curcumin analog: A review
  11. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines
  12. Cerebral bioenergetics in hypovolemic shock: Mechanistic insights into the efficacy of EF24.
  13. Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous …
  14. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells
  15. Curcuminoid EF24 enhances the anti‐tumour activity of Akt inhibitor MK‐2206 through ROS‐mediated endoplasmic reticulum stress and mitochondrial dysfunction in …
  16. Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
  17. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
  18. Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells
  19. Diphenyldihaloketones CLEFMA and EF24 target RPN13 for pharmacotherapy of gut barrier dysfunction in hemorrhagic shock
  20. EF24 (a curcumin analog) and ZSTK474 emphasize the effect of cabozantinib in medullary thyroid cancer
  21. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects …
  22. EF24 attenuates radiation-regulated eNOS→ NO-dependent NFκB-mediated matrix metalloproteinases in human neuroblastoma
  23. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression
  24. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by inhibiting proteasomal degradation of pten
  25. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
  26. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma
  27. EF24 prevents rotenone‐induced estrogenic status alteration in breast cancer
  28. EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
  29. EF24 suppresses invasion and migration of hepatocellular carcinoma cells in vitro via inhibiting the phosphorylation of Src
  30. EF24 suppresses maturation and inflammatory response in dendritic cells
  31. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
  32. EF24, a novel curcumin analogue inhibits oncogenic activation induced by radiation abscopal effect in distant mice lungs
  33. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
  34. Effects of a Curcumin Analog, EF24, on Reproductive Function in Rats.
  35. Evaluation of the High Mobility Group A1 proteins (HMGA1) as a key mediate in the anticancer activity of-EF24.
  36. Evaluation of the Potential HMGA1-EF24 Nexus in Human Colon Cancer
  37. Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects
  38. HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells
  39. Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model
  40. Hypoxia‐mediated sorafenib resistance can be overcome by EF24 through Von Hippel‐Lindau tumor suppressor‐dependent HIF‐1α inhibition in hepatocellular …
  41. Impressive suppression of colon cancer growth by triple combination SN38/EF24/melatonin:“oncogenic” versus “onco-suppressive” reactive oxygen species
  42. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog
  43. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24
  44. Inhibition of IκB kinase-nuclear factor-κB signaling pathway by 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin
  45. Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model
  46. MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by …
  47. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells
  48. Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival
  49. Radiosensitization of glioma cells with the curcumin analogs EF24 and EF31
  50. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA
  51. Study on the relationship between autophagy and apoptosis in A549 cells induced by curcumin analogue EF24
  52. Synergistic anticancer potential of the combination of the novel curcumin analog EF24 and p38 MAPK inhibitors
  53. Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer
  54. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors
  55. Synthesis of EF24− tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system
  56. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa
  57. The curcumin analog EF24 is a novel senolytic agent
  58. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo
  59. The impact of curcumin analogs EF24 on HepG2 and the development of zebra fish embryo [J]
  60. The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model
  61. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 with the 26S Proteasome
Related Posts

Gossypol

Schizonepeta Tenuifolia

Luteolin

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping